MARVER DAVID L 4
4 · Cardiac Science CORP · Filed Apr 2, 2009
Insider Transaction Report
Form 4
MARVER DAVID L
DirectorPresident & CEO
Transactions
- Award
Stock Options
2009-03-31+140,000→ 140,000 totalExercise: $3.01From: 2010-03-31Exp: 2019-03-31→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest 12 months after the Vesting Commencement Date and 1/36th of the remaining shares vest monthly thereafter for the next 36 months.